Brief: genOway Grants CRISPR/Cas9 License To U.K. Academic Research Funder
25/01/2022 10:03
Jan 25 (Reuters) - GENOWAY SA ALGEN.PA :
* ANNOUNCED TODAY THAT IT HAS GRANTED A NON-EXCLUSIVE
CRISPR/CAS9
LICENSE TO MOST IMPORTANT FUNDING INSTITUTION OF BIOMEDICAL
ACADEMIC RESEARCH IN UNITED KINGDOM
* GENOWAY'S STRATEGY IS TO PROVIDE A SUBLICENSE ON THIS
CRISPR
TECHNOLOGY TO SELECT PARTNERS AND PROVIDE THEM WITH COMPETITIVE
ADVANTAGES
Source text for Eikon: ID:nPreC8LvQa
Further company coverage: ALGEN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))